NCT04335084View on ClinicalTrials.gov

A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

May 31, 2022

Study Completion Date

April 11, 2024

Conditions
COVID-19Coronavirus InfectionSars-CoV2Corona Virus InfectionCOVIDCoronavirusCoronavirus-19Coronavirus 19
Interventions
DRUG

Hydroxychloroquine

Prophylaxis treatment for COVID-19

DIETARY_SUPPLEMENT

Vitamin C

Prophylaxis treatment for COVID-19

DIETARY_SUPPLEMENT

Vitamin D

Prophylaxis treatment for COVID-19

DIETARY_SUPPLEMENT

Zinc

Prophylaxis treatment for COVID-19

Trial Locations (1)

93003

ProgenaBiome, Ventura

Sponsors

Lead Sponsor

ProgenaBiome
All Listed Sponsors
collaborator

DSCS CRO

INDUSTRY

lead

ProgenaBiome

OTHER

NCT04335084 - A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection | Biotech Hunter | Biotech Hunter